ID: MRFR/HC/7665-CR | 95 Pages | Author: Rahul Gotadki | January 2022
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 SCOPE OF THE STUDY
2.2 RESEARCH OBJECTIVE
2.3 MARKET STRUCTURE
2.4 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING NUMBER OF OBESE CASES ACROSS THE GLOBE
4.2.2 RISING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
4.2.3 GROWING MEDICAL TOURISM INDUSTRY
4.3 RESTRAINTS
4.3.1 CONCERNS PERTAINING TO BRUISING AND SWELLING
4.3.2 SHORTAGE OF TRAINED AND EXPERIENCED DERMATOLOGIST/ PLASTIC SURGEON
4.4 OPPORTUNITY
4.4.1 GROWING ADOPTION OF COSMETIC PROCEDURES IN EMERGING ECONOMIES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE GLOBAL CELLULITE TREATMENT MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PATIENTS SUFFERING FROM CELLULITE
5.3.3 IMPACT ON DEMAND AND SUPPLY
5.3.4 IMPACT ON REGIONS
6 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE
6.1 OVERVIEW
6.2 NON-INVASIVE
6.3 TOPICAL
6.4 MINIMALLY INVASIVE
6.5 OTHERS
7 GLOBAL CELLULITE TREATMENT MARKET, BY CELLULITE TYPE
7.1 OVERVIEW
7.2 SOFT CELLULITE
7.3 HARD CELLULITE
7.4 EDEMATOUS CELLULITE
8 GLOBAL CELLULITE TREATMENT MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.3 SPECIALISED DERMATOLOGY CLINICS
8.4 AMBULATORY SURGICAL CENTERS
8.5 OTHERS
9 GLOBAL CELLULITE TREATMENT MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 UK
9.3.3 FRANCE
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 INDIA
9.4.4 SOUTH KOREA
9.4.5 AUSTRALIA
9.4.6 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
9.5.1 MIDDLE EAST
9.5.2 AFRICA
9.5.3 LATIN AMERICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 COMPETITIVE BENCHMARKING
10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL CELLULITE TREATMENT MARKET
10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL CELLULITE TREATMENT MARKET
10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.5.1 PRODUCT LAUNCH/PRODUCT APPROVAL
11 COMPANY PROFILES
11.1 HOLOGIC, INC.
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 PRODUCTS/SERVICES OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 NUBWAY CO.LTD.
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 PRODUCTS/SERVICES OFFERED
11.2.4 KEY DEVELOPMENTS
11.2.5 SWOT ANALYSIS
11.2.6 KEY STRATEGIES
11.3 MERZ PHARMA GMBH & CO. KGAA
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 PRODUCTS/SERVICES OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 SWOT ANALYSIS
11.3.6 KEY STRATEGIES
11.4 ZIMMER AESTHETICS
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 PRODUCTS/SERVICES OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 CYMEDICS
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS/SERVICES OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 CYNOSURE, LLC
11.6.1 COMPANY OVERVIEW
11.6.2 FINANCIAL OVERVIEW
11.6.3 PRODUCTS/SERVICES OFFERED
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIES
11.7 INCELER MEDIKAL CO. LTD.
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS/SERVICES OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 KEY STRATEGIES
11.8 CANDELA MEDICAL
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 PRODUCTS/SERVICES OFFERED
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 CUTERA, INC.
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 PRODUCTS/SERVICES OFFERED
11.9.4 KEY DEVELOPMENTS
11.9.5 KEY STRATEGIES
11.10 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 PRODUCTS/SERVICES OFFERED
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
12 APPENDIX
12.1 REFERENCES
12.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 4 GLOBAL: CELLULITE TREATMENT MARKET, FOR NON-INVASIVE, BY REGION, 2018–2027 (USD MILLION)
TABLE 5 GLOBAL: CELLULITE TREATMENT MARKET, FOR TOPICAL, BY REGION, 2018–2027 (USD MILLION)
TABLE 6 GLOBAL: CELLULITE TREATMENT MARKET, FOR MINIMALLY INVASIVE, BY REGION, 2018–2027 (USD MILLION)
TABLE 7 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 8 GLOBAL: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 9 GLOBAL: CELLULITE TREATMENT MARKET, FOR SOFT CELLULITE, BY REGION, 2018–2027 (USD MILLION)
TABLE 10 GLOBAL: CELLULITE TREATMENT MARKET, FOR HARD CELLULITE, BY REGION, 2018–2027 (USD MILLION)
TABLE 11 GLOBAL: CELLULITE TREATMENT MARKET, FOR EDEMATOUS CELLULITE, BY REGION, 2018–2027 (USD MILLION)
TABLE 12 GLOBAL: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 13 GLOBAL: CELLULITE TREATMENT MARKET, FOR HOSPITALS, BY REGION, 2018–2027 (USD MILLION)
TABLE 14 GLOBAL: CELLULITE TREATMENT MARKET, FOR SPECIALISED DERMATOLOGY CLINICS, BY REGION, 2018–2027 (USD MILLION)
TABLE 15 GLOBAL: CELLULITE TREATMENT MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 16 GLOBAL: CELLULITE TREATMENT MARKET, FOR OTHERS, BY REGION, 2018–2027 (USD MILLION)
TABLE 17 GLOBAL: CELLULITE TREATMENT MARKET, BY REGION, 2018–2027 (USD MILLION)
TABLE 18 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 19 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 20 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 21 NORTH AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 22 US: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 23 US: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 24 US: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 25 CANADA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 26 CANADA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 27 CANADA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 28 EUROPE: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 29 EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 30 EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 31 EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 32 GERMANY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 33 GERMANY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 34 GERMANY: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 35 UK: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 36 UK: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 37 UK: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 38 FRANCE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 39 FRANCE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 40 FRANCE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 41 ITALY: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 42 ITALY: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 43 ITALY: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 44 SPAIN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 45 SPAIN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 46 SPAIN: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 47 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 48 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 49 REST OF EUROPE: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 50 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 51 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 52 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 53 ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 54 CHINA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 55 CHINA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 56 CHINA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 57 JAPAN: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 58 JAPAN: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 59 JAPAN: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 60 INDIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 61 INDIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 62 INDIA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 63 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 64 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 65 SOUTH KOREA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 66 AUSTRALIA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 67 AUSTRALIA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 68 AUSTRALIA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 69 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 70 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 71 REST OF ASIA PACIFIC: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 72 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY COUNTRY, 2018–2027 (USD MILLION)
TABLE 73 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 74 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 75 REST OF THE WORLD: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 76 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 77 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 78 MIDDLE EAST: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 79 AFRICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 80 AFRICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 81 AFRICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 82 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2018–2027 (USD MILLION)
TABLE 83 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY CELLULITE TYPE, 2018–2027 (USD MILLION)
TABLE 84 LATIN AMERICA: CELLULITE TREATMENT MARKET, BY END USER, 2018–2027 (USD MILLION)
TABLE 85 MAJOR PLAYERS IN THE GLOBAL CELLULITE TREATMENT MARKET
TABLE 86 MOST ACTIVE PLAYER IN THE GLOBAL CELLULITE TREATMENT MARKET
TABLE 87 PRODUCT LAUNCH/PRODUCT APPROVAL
TABLE 88 HOLOGIC, INC: PRODUCTS/SERVICES OFFERED
TABLE 89 NUBWAY CO.LTD.: PRODUCTS/SERVICES OFFERED
TABLE 90 MERZ PHARMA GMBH & CO. KGAA: PRODUCTS/SERVICES OFFERED
TABLE 91 ZIMMER AESTHETICS: PRODUCTS/SERVICES OFFERED
TABLE 92 CYMEDICS: PRODUCTS/SERVICES OFFERED
TABLE 93 CYNOSURE, LLC: PRODUCTS/SERVICES OFFERED
TABLE 94 INCELER MEDIKAL CO. LTD.: PRODUCTS/SERVICES OFFERED
TABLE 95 CANDELA MEDICAL: PRODUCTS/SERVICES OFFERED
TABLE 96 CUTERA, INC.: PRODUCTS/SERVICES OFFERED
TABLE 97 CUTERA, INC.: KEY DEVELOPMENTS
TABLE 98 BEIJING SINCOHEREN S & T DEVELOPMENT CO., LTD.: PRODUCTS/SERVICES OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 MARKET STRUCTURE: GLOBAL CELLULITE TREATMENT MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: GLOBAL CELLULITE TREATMENT MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL CELLULITE TREATMENT MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL CELLULITE TREATMENT MARKET
FIGURE 9 GLOBAL CELLULITE TREATMENT MARKET, BY TREATMENT PROCEDURE, 2020 & 2027 (USD MILLION)
FIGURE 10 GLOBAL: CELLULITE TREATMENT MARKET, CELLULITE TYPE, 2020 & 2027 (USD MILLION)
FIGURE 11 GLOBAL: CELLULITE TREATMENT MARKET, END USER, 2020 & 2027 (USD MILLION)
FIGURE 12 GLOBAL: CELLULITE TREATMENT MARKET, BY REGION 2020 & 2027 (USD MILLION)
FIGURE 13 GLOBAL: CELLULITE TREATMENT MARKET SHARE (%), BY REGION, 2020
FIGURE 14 NORTH AMERICA: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020
FIGURE 15 EUROPE: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020
FIGURE 16 ASIA PACIFIC: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020
FIGURE 17 REST OF THE WORLD: CELLULITE TREATMENT MARKET SHARE (%), BY COUNTRY 2020
FIGURE 18 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 19 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN THE GLOBAL CELLULITE TREATMENT MARKET
FIGURE 20 HOLOGIC, INC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 21 HOLOGIC, INC: SWOT ANALYSIS
FIGURE 22 NUBWAY CO.LTD.: SWOT ANALYSIS
FIGURE 23 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS
FIGURE 24 ZIMMER AESTHETICS: SWOT ANALYSIS
FIGURE 25 CYMEDICS: SWOT ANALYSIS
Market Segmentation
Cellulite Treatment Treatment Procedure Outlook (USD Billion, 2018-2030)
Non-Invasive
Minimally-Invasive
Topical Treatment
Cellulite Treatment Cellulite Type Outlook (USD Billion, 2018-2030)
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Cellulite Treatment End Use Outlook (USD Billion, 2018-2030)
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Cellulite Treatment Regional Outlook (USD Billion, 2018-2030)
North America Outlook (USD Billion, 2018-2030)
North America Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
North America Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
North America Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
US Outlook (USD Billion, 2018-2030)
US Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
US Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
US Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Canada Outlook (USD Billion, 2018-2030)
Canada Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Canada Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Canada Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Europe Outlook (USD Billion, 2018-2030)
Europe Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Europe Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Europe Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Germany Outlook (USD Billion, 2018-2030)
Germany Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Germany Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Germany Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
France Outlook (USD Billion, 2018-2030)
France Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
France Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
France Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
UK Outlook (USD Billion, 2018-2030)
UK Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
UK Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
UK Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Italy Outlook (USD Billion, 2018-2030)
Italy Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Italy Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Italy Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Spain Outlook (USD Billion, 2018-2030)
Spain Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Spain Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Spain Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Rest Of Europe Outlook (USD Billion, 2018-2030)
Rest Of Europe Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Rest Of Europe Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Rest Of Europe Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Asia-Pacific Outlook (USD Billion, 2018-2030)
Asia-Pacific Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Asia-Pacific Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Asia-Pacific Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
China Outlook (USD Billion, 2018-2030)
China Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
China Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
China Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Japan Outlook (USD Billion, 2018-2030)
Japan Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Japan Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Japan Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
India Outlook (USD Billion, 2018-2030)
India Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
India Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
India Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Australia Outlook (USD Billion, 2018-2030)
Australia Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Australia Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Australia Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)
Rest of Asia-Pacific Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Rest of Asia-Pacific Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Rest of Asia-Pacific Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Rest of the World Outlook (USD Billion, 2018-2030)
Rest of the World Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Rest of the World Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Rest of the World Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Middle East Outlook (USD Billion, 2018-2030)
Middle East Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Middle East Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Middle East Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Africa Outlook (USD Billion, 2018-2030)
Africa Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Africa Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Africa Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Latin America Outlook (USD Billion, 2018-2030)
Latin America Cellulite Treatment by Treatment Procedure
Non-Invasive
Minimally-Invasive
Topical Treatment
Latin America Cellulite Treatment by Cellulite Type
Hard Cellulite
Soft Cellulite
Edematous Cellulite
Latin America Cellulite Treatment by End Use
Hospitals
Ambulatory Surgical Centers
Specialized Dermatology Clinics
Research Methodology on Cellulite Treatment Market
1. Introduction
Cellulite Treatment Market comprises various solutions which are used for the treatment of cellulite on different parts of the body such as the thighs, butt, and abdomen. The current demand for non-invasive techniques for the treatment and changing lifestyle patterns are augmenting the market growth.
This research report provides an in-depth analysis of the global Cellulite Treatment Market in terms of market size and forecast for 2023 to 2030. The report provides insights into the latest developments and trends in the market. It also evaluates the competitive landscape of the market through secondary sources.
2. Objectives of the Study
The objective of this research study is to analyze the market trends in terms of size, share, pricing structure, growth drivers, emerging trends, and other relevant factors. The study also includes an analysis of the competitive landscape of the market.
3. Research Scope
The scope of this research study is to analyze the global Cellulite Treatment Market, both in terms of value and volume. The market analysis has been conducted across five key regions – North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
4. Research Methodology
This research study has used both primary and secondary research sources to collect data and information on the global Cellulite Treatment Market. The primary research sources included industry experts and market analysts.
The secondary research sources included annual reports, company websites, press releases, and financial reports. The research used a bottom-up approach to estimate the market size in terms of value and volume. It also used an appropriate combination of qualitative and quantitative research methods to analyze the market dynamics and trends.
5. Market Estimation and Forecast
The market estimates and forecasts were based on the analysis of the global Cellulite Treatment Market. The data was gathered from both primary and secondary sources. The primary sources included external and internal sources, such as press releases, industry surveys, interviews with industry experts, and press interviews.
The secondary sources included databases such as Factiva, Bloomberg, and Marketing Intelligence Tools. The data was further validated by conducting multiple rounds of validation with industry experts and experts from the industry.
The market was segmented based on geography, technology, product type, and application. The market size and forecast were estimated based on the analysis of the data collected from primary and secondary sources.
The market estimates and forecasts were calculated using statistical tools such as arithmetic mean, median, mode, standard deviation, and Z-Score Analysis. The market estimates and forecasts were validated using past data analysis and market trends.
6. Data Collection and Analysis
The data used for the research was collected from both primary and secondary sources. The primary sources consisted of industry experts, industry publications, surveys, and interviews. The secondary sources included Factiva, Bloomberg, and Marketing Intelligence Tools.
The data were analyzed using statistical tools such as mean, median, mode, and standard deviation. The data was further validated using the top-down approach and bottom-up approach. The data were also analyzed using the Z-Score Analysis to validate the results.
7. Results and Findings
The results of the research study are summarized as follows:
The Cellulite Treatment Market is estimated to expand at a significant CAGR from 2023 to 2030.
North American region holds a significant share of the global Cellulite Treatment Market.
The market is segmented based on technology, product type, and application.
The growth of the market is driven by the rising prevalence of cellulite, increasing awareness among consumers, and preference for non-invasive treatment options.
The key players in the market include Cynosure, Inc., Solta Medical, Inc., Lumenis, Merz Pharma GmbH & Co. KGaA, Integra LifeSciences Corporation, and Teoxane Laboratories.